medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2013, Number 02

<< Back Next >>

Ginecol Obstet Mex 2013; 81 (02)

Knowledge and acceptance of vaccine against human papillomavirus among mothers of students from Durango city, Mexico

Sánchez ALF, Lechuga QAM, Milla VRH, Lares BEF

Language: Spanish
References: 33
Page: 77-85
PDF size: 439.76 Kb.


ABSTRACT

Background: Human papillomavirus (HPV) causes one of the most common sexually transmitted infections. The causal relationship between HPV and cervical cancer is one of the most important advances in the field of the prevention of this disease. The Food and Drug Administration recently approved two vaccines to prevent HPV infection.
Objective: To assess the degree of knowledge about HPV and the acceptance of the vaccine against these viruses in mothers of 9 to 15 years old female students from the city of Durango, Mexico.
Material and method: A prospective, observational, cross-sectional and descriptive study of 470 mothers. The selection was made through random sampling stratified by age and socio-economic status of students from public and private schools in the city of Durango. We applied a questionnaire of 60 questions, 12 open and 48 closed. Groups of acceptance of the vaccine were compared by Student’s t and χ2, depending on the type of variable. Reasons for prevalence of non-acceptance and its 95% of risk confidence interval were estimated.
Results: The 94% of the women surveyed knew about the vaccine. The 89% would accept vaccination of their daughters if it was free of charge, but only 40% would be willing to buy it; 88% considered that was important to their daughters to receive extensive information about the vaccine from nine years of age. The risk factors identified in this study to not allow vaccination were: not knowing the existence of the vaccine, which increased this risk 3.5 times; not having comprehensive information of the sexually transmitted diseases, which increased it by 2.49 times; and the fear to initiate their sexual life at younger age, which raised it 4.58 times. No difference was found in acceptance to the vaccine for religious or socio-economic reasons; 9% of mothers did not accept the vaccine despite of knowing its existence and the role of HPV in the genesis of cervical cancer.
Conclusion: The vast majority of surveyed mothers accepted vaccination. The degree of knowledge about the vaccine is an important factor for its acceptance.


REFERENCES

  1. Bosch FX, de Sanjosé S. Human papillomavirus in cervical cancer. Curr Oncol Rep 2002;4(2):175-183.

  2. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, et. al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.

  3. de Villiers EM, Fauquet C, Broker TR, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.

  4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.

  5. Muñoz N, Mendez F, Posso H, Molano, et al. Incidence, duration and determinants of cervical human papillomavirus infection in a cohort of colombian women with normal cytological results. J Infect Dis 2004;190:2077-2087.

  6. Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud Pública Méx 2003;45(suppl 3):S306-S314.

  7. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.

  8. Phillips C. Use and acceptance of HPV vaccine still a work in progress. NCI Bull 2011;3:9-14.

  9. Bobe-Arnant F, Buil-Arasanz ME, Morro-Grau A, Trubat-Muñoz G. Aceptación de la vacunación del VPH por parte de los padres de las niñas de 6o de primaria. Un año después. Aten Primaria 2010;42:628-629.

  10. Lazcano-Ponce E, Rivera L, Arillo-Santillán E, Salmerón J y col. Aceptabilidad de la vacuna para el virus del papiloma humano (VPH) entre madres de adolescentes en Cuernavaca, México. Arch Med Res 2001;32:243-247.

  11. Arrossi S, Maceira V, Paolino M, Mazzadi A. Conocimientos y aceptabilidad de la vacuna contra el HPV entre médicos ginecólogos en Argentina. IX Jornadas Nacionales de Debate Interdisciplinario en Salud y Población. Buenos Aires: Facultad de Ciencias Económicas, Universidad de Buenos Aires, 10-12 de agosto de 2011.

  12. Estrategias para el suministro de la vacuna del virus del papiloma humano que consiguieron una alta cobertura en países con ingresos bajos y medios. Boletín de la Organización Mundial de la Salud 2011;89:777-852.

  13. ¿Vacuna del papiloma humano, sí o no? Disponible en: http://www.misionlandia.com.ar/index.php/salud/item1842- %C2%BFvacuna-del-papiloma-humano-s%C3%AD-o-no?. html. 4 de julio de 2012.

  14. Liddon NC, Hood JE, Leichliter JS. Intent to receive HPV vaccine and reasons for no vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth. Vaccine 2012;30:2676- 2682.

  15. Vanderpool RC, Casey BR, Crosby RA. HPV-related risk perceptions and HPV vaccine among a sample of young rural women. J Community Health 2011:36:903-909.

  16. Habel MA, Liddon N, Stryker JE. The HPV vaccine: a content analysis of oneline news stories. J Womens Health (Larchmt) 2009;18:401-407.

  17. Abdelmutti N, Hoffman-Goetz L. Risk messages about HPV, cervical cancer, and HPV vaccine Gardasil in North American news magazines. J Cancer Educ 2010;25:451-456.

  18. Wacholder S, Chen BE, Wilcox A, Macones G, et al. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomized controlled trials. BMJ 2010;340:712.

  19. Disponible en: http://www.inegi.org.mx/est/contenidos/espanol/ sistemas/regsoc/default.asp?s=est&c=11723 INEGI – 2011).

  20. Información Digital INEGI Microdatos II CPV 2005.

  21. Hughes J, Cates JR, Lindon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009;18:363-372.

  22. Jaspers L, Budiningshi S, Wolterbeek R, Henderson FC, Peters AA. Parenteral acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine 2011;29;7785-7793.

  23. Ruffin MT, Hade EM, Gorsline MR, de Graffinreid CR, et al. Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio. Vaccine 2012;30:5349-5357.

  24. Chelimo C, Wouldes TA, Cameron LD. Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand University students. Sex Health 2010;7:394-396.

  25. Schmeink CE, Gosens KC, Melchers WJ, Massuger LF, Bekkers RL. Young adults awareness of HPV and vaccine acceptance after introduction of HPV vaccine in Dutch national vaccination program. Eur J Gynaecol Oncol 2011;32:481-486.

  26. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health 2007;40:108-115.

  27. Hanley SJ, Yoshioka E, Ito Y, Konno R, et al. Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls. Vaccine 2012;30:5740-5747.

  28. Reynolds SJ, O’Connell KA. Testing a model for parental acceptance of human papillomavirus vaccine in 9 to 18 year old girls: A theory-guided study. J Pediatr Nurs 2011;2(Epub ahead print).

  29. Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 2010;1:10-27.

  30. van der Berg JD, Roorda J, Westerman MJ. Reasons not to have daughter vaccinated against the human papillomavirus in Twente: a questionnaire study. Ned Tijdsch Geneeskd 2010;154:A1923.

  31. Young A. HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pac J Cancer Prev 2010;11:641-649.

  32. Ferris DG, Waller JL, Owen A, Smith J. HPV vaccine acceptance among mid-adult women. J Am Board Fam Med 2008;21:31-37.

  33. Sánchez-Anguiano LF, Alvarado-Esquivel C, Reyes Romero MA, Carrera Rodríguez M. Human papillomavirus infections in women seeking Papanicolaou citology of Durango. BMC Infect Dis 2006;6:27-34.




2020     |     www.medigraphic.com